Federal Court Deadline Looms on Mailed Abortion Medication Access
A federal court deadline on Monday could make mailing abortion pills illegal nationwide. The ruling would affect telemedicine providers who prescribe mifepristone and misoprostol to patients across state lines, including for medication abortion and miscarriage management. Providers currently rely on FDA guidance allowing direct-to-patient mailing of abortion medications approved during the COVID-19 public health emergency and maintained afterward. If the deadline results in restrictions, it could eliminate a key access pathway for medication abortion in states where in-person abortion services are limited or banned.
Medicaid managed care organizations covering maternity benefits would see increased demand for in-person pregnancy-related services if telemedicine abortion medication access is eliminated, particularly in states with abortion restrictions where members have relied on out-of-state prescribers.
Maternal · Managed Care
You might also like